Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PFIZER INC Director's Dealing 2011

Dec 20, 2011

29831_dirs_2011-12-19_3d003976-4f21-4ca2-bdcc-de5e4413d51f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2011-12-15

Reporting Person: LANKLER DOUGLAS M (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-12-16 Common Stock I 1868.0000 $21.0300 Disposed 0.0000 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-12-15 Phantom Stock Units SSP $ A 95.0000 Acquired Common Stock (95.0000) Direct
2011-12-16 Phantom Stock Units SSP $ I 9271.0000 Disposed Common Stock (9271.0000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 113856.0000 Direct

Footnotes

F1: This transaction constitutes an intra-plan transfer involving the Pfizer stock fund under the Company's Qualified Savings Plan.

F2: Each unit represents one phantom share of common stock.

F3: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

F4: This transaction constitutes an intra-plan transfer involving the Pfizer stock unit fund under the Pfizer stock unit fund under the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan.